UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000053294
Receipt number R000060826
Scientific Title An exploratory study of methylenetetrahydrofolate reductase (MTHFR) gene polymorphism frequencies in men and women of reproductive age
Date of disclosure of the study information 2024/02/01
Last modified on 2024/01/09 10:57:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

An exploratory study of methylenetetrahydrofolate reductase (MTHFR) gene polymorphism frequencies in men and women of reproductive age

Acronym

An exploratory study of methylenetetrahydrofolate reductase (MTHFR) gene polymorphism frequencies in men and women of reproductive age

Scientific Title

An exploratory study of methylenetetrahydrofolate reductase (MTHFR) gene polymorphism frequencies in men and women of reproductive age

Scientific Title:Acronym

An exploratory study of methylenetetrahydrofolate reductase (MTHFR) gene polymorphism frequencies in men and women of reproductive age

Region

Japan


Condition

Condition

Reproductive age Men and women suspected of infertility

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To explore genotype frequencies of the following MTHFR genotypes in men and women of reproductive age and determine their impact on reproductive function test items.

Basic objectives2

Bio-equivalence

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

genotype frequencies of the following MTHFR genotypes in men and women of reproductive age

Key secondary outcomes

Male:
Semen analysis (semen volume, sperm concentration, motility), semen oxidation-reduction potential (sORP test), sperm DNA fragmentation index test (sperm DFI test)
History of urological diseases and surgeries at the time of interview, sexual desire and sexual intercourse, SHIM diagnostic test results, etc.
Measurement of serum folate and homocysteine
Women
Menstrual estrogen, progesterone, LH, FSH, PRL, AMH, etc.
Results of questionnaires on menstruation, pregnancy, medications/medical history, surgical history, infertility treatment history, etc. at the time of interview
Serum folate and homocysteine levels


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. have been fully informed of the purpose and content of the study, have the capacity to consent, and have volunteered to participate of their own free will with full understanding, and have agreed to participate in writing
2. Men and women must be at least 20 years of age at the time of participation.

Key exclusion criteria

Those deemed ineligible at the discretion of the principal investigator

Target sample size

1000


Research contact person

Name of lead principal investigator

1st name Kiyotaka
Middle name
Last name Kawai

Organization

Kameda IVF Clinic MAKUHARI

Division name

reproductive medicine

Zip code

2618501

Address

1-3D3F Nakase Mihama-ku Ciba-city Chiba Japan

TEL

81-43-296-8141

Email

kawai.kiyotaka@kameda.jp


Public contact

Name of contact person

1st name Kiyotaka
Middle name
Last name Kawai

Organization

Kameda IVF Clinic MAKUHARI

Division name

Reproductive medicine

Zip code

26108501

Address

1-3D3F Nakase Mihama-ku Ciba-city Chiba Japan

TEL

81-43-296-8141

Homepage URL


Email

kawai.kiyotaka@kameda.jp


Sponsor or person

Institute

Kameda IVF Clinic Makuhari

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kameda General Hospital

Address

929 Higashi-cho Kamogawa-city Chiba Japan

Tel

81470922211

Email

kawai.kiyotaka@kameda.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 02 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2022 Year 01 Month 09 Day

Date of IRB


Anticipated trial start date

2024 Year 02 Month 01 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

none


Management information

Registered date

2024 Year 01 Month 09 Day

Last modified on

2024 Year 01 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060826